The Arkansas Chapter of the Cystic Fibrosis Foundation held another successful edition of its Breath of Life…
Articles by Patrícia Silva, PhD
Bayer HealthCare, a global leader in respiratory medicine, recently announced it has received qualified infectious disease product (QIDP) designation…
Last month, the Cystic Fibrosis Foundation celebrated the 20th year of its annual golf tournament and successful…
Anthera Pharmaceuticals, Inc., a biopharmaceutical company that specializes in research and development of novel treatments for serious and fatal diseases such…
Clinical-stage biopharmaceutical company, N30 Pharmaceuticals, recently announced that it raised $30 million in a mezzanine round of financing, which will…
A project for a tablet-based software tool designed to help children suffering from lung diseases properly use nebulizers, which…
The Chief Executive of the Cystic Fibrosis Trust recently wrote a letter to the NHS…
A group of undergraduate researchers from Dundee University are the proud recipients of 3 prizes from a conference in…
All over the country and throughout the world, local communities organize events to raise both awareness and funds to…
Massachusetts-based Vertex Pharmaceuticals, Inc. announced yesterday that they have filed for a New Drug Application (NDA) with the…